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We identify ef1090 (renamed ebpR) and show its importance for the transcriptional regulation of expression
of the Enterococcus faecalis pilus operon, ebpABC. An ebpR deletion (ebpR) mutant was found to have reduced
ebpABC expression with loss of pilus production and a defect in primary adherence with, as a consequence,
reduced biofilm formation.
Enterococcus faecalis is a gram-positive bacterium that is
part of the normal intestinal flora of most humans but is also
a major cause of opportunistic infection (9). A major regulator
of virulence in E. faecalis OG1RF is the Fsr system (15). In a
previous microarray analysis, we identified several Fsr-regu-
lated genes encoding putative regulators, one of which was
ef1090 (2). EF1090 contains two putative helix-turn-helix
DNA-binding domains and shares 42% similarity with AcpB
from Bacillus anthracis, a member of the AtxA/MgaA family
(4). Upstream and in the opposite orientation of ef1090 is the
ebpABC operon, which encodes pilus components shown to be
important for virulence in the rat endocarditis model and the
mouse urinary tract infection model (13, 17).
To test whether the putative EF1090 regulator was involved
in the regulation of the pili genes, we first performed semi-
quantitative reverse transcription-PCR (qRT-PCR) (2). The
ebpA, ebpB, and ebpC transcripts were strongly reduced in an
ef1090 transposon insertion mutant (5) compared to the par-
ent strain (data not shown). Based on these results, ef1090 was
renamed ebpR for its role as an endocarditis- and biofilm-
associated pilus regulator. To prevent any effects caused by the
transposon insertion from complicating our analysis, we then
created an unmarked in-frame ebpR deletion mutant (Table 1)
of OG1RF by using the recently published PheS* system (7).
The ebpR mutant had no growth defects compared to
OG1RF in BHI, TSBG (biofilm medium), or BHI-40% horse
serum (binding assay medium).
To assess transcriptional differences between OG1RF and
the ebpR mutant, we used microarray analysis with slide prep-
aration (1), probe labeling, hybridization, data acquisition, and
statistical analysis performed as described previously (2). RNA
was extracted at late log growth phase from TSBG-grown cul-
tures (2). Within the level of detection of the microarray anal-
ysis, the ebpABC transcript was undetectable in the ebpR
mutant compared to OG1RF, indicating that ebpR is important
for ebpABC expression at the transcriptional level. srtC was not
significantly altered in these conditions. We confirmed these
results by using qRT-PCR (12). The amount of transcript for
each gene of interest was normalized against gyrB transcripts.
qRT-PCR showed that ebpA transcripts levels were decreased
119-fold (P  0.0018) in the ebpR mutant versus the wild type,
whereas srtC transcripts were only 1.7-fold decreased (P 
0.028) (Fig. 1A). The slight effect of ebpR on srtC is likely
related to the presence of an independent srtC promoter and
the low level of readthrough from the ebpA promoter de-
scribed previously (13). Since basal ebpABC expression was
detected in our ebpR mutant, our results indicate that ebpR,
although important, is not essential for ebpABC expression.
To begin examining how epbR is regulated, we mapped the
transcriptional start site of OG1RF. Using the RACE (for
rapid amplification of cDNA ends) kit, only one start site for
ebpR was found at 21 bp. Looking at the promoter area, no
canonical10 and35 bp sequences were detected, indicating
that the expression of ebpR is likely sigma A independent. We
next looked at possible ebpR autoregulation by inserting a
301-bp fragment overlapping the entire 209-bp region separat-
ing ebpA from ebpR into pTCV-lacZ to create a transcriptional
lacZ fusion. The -galactosidase activity of this construct in an
ebpR background compared to the wild type was measured (6).
No -galactosidase activity was detected using the PebpR::lacZ
fusion in the ebpR mutant, whereas it was detectable in the wild
type (Fig. 1B). The results indicate that ebpR is autoactivated.
In addition to examining transcript levels, we examined pilus
production in the wild type (OG1RF), the ebpR mutant
(TX5514), and a complemented strain (TX5582) in which ebpR
was cloned under the control of the nisin promoter in
pMSP3535 (3). As determined by RT-PCR, the expression of
ebpR in TX5582 was detected even without nisin (data not
shown). In order to detect the pili, mutanolysin extracts were
made from OG1RF as described previously (13). As seen be-
fore, a ladder profile was detected using antibodies to EbpA
(Fig. 2, lane 1). It was not observed in extracts from the ebpR
mutant (lane 2) or in extracts from the mutant carrying the
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empty vector (lane 3). However, it was detected in the com-
plemented strain (Fig. 2, lane 4). A similar result was observed
using EbpC antibodies (data not shown).
Nallapareddy et al. reported that only 10 to 20% of OG1RF
cells had observable pili by electron microscopy (13). To eval-
uate this observation using another methodology, intact bac-
teria fixed with 4.4% (wt/vol) paraformaldehyde were probed
with anti-EbpA or anti-EbpC rabbit antibodies by indirect im-
TABLE 1. Strains, plasmids, and primers used in this study
Strain or plasmid Relevant characteristics or sequencea Source orreference
Strains
E. coli
TG1 E. coli general cloning host 16
EC1000 E. coli cloning host for repA-dependent plasmids; carries constitutive repA allele on chromosome; Kanr 8
E. faecalis
OG1RF E. faecalis Fusr Rif r; p-Cl-Pher 11
CK111/pCF10-101 E. faecalis conjugative donor strain; carries constitutive repA allele on chromosome and nontransferable pCF10
derivative; Spcr Tetr
7
DAGF27 Tn917 transposon insertion at 581 bp from the ebpRa ATG in OG1RF; Ermr Fusr Rif r 5
TX5475 ebpA allelic replacement aph(3)-IIIa mutant of OG1RF; Fusr Kanr Rif r 13
TX5460 ebpB insertion disruption mutant of OG1RF; Fusr Kanr Rif r 13
TX5448 ebpC insertion disruption mutant of OG1RF; Fusr Kanr Rif r 13
TX5514 ebpR in-frame deletion from bp 5 to 1337 from the ATG of ebpR of OG1RF; Fusr Rif r; p-Cl-Pher This study
TX5584 TX5514(pMSP3535); Ermr Fusr Rif r; p-Cl-Pher This study
TX5582 TX5514(pTEX5515); ebpR mutant containing ebpR gene inserted into pMSP3535; Ermr Fusr Rif r; p-Cl-Pher This study
TX5590 OG1RF(pTEX5586); OG1RF containing the ebpR promoter fused to lacZ; Ermr Fosr Rifr This study
TX5591 TX5514(pTEX5586); ebpR mutant containing the ebpR promoter fused to lacZ; Ermr This study
Plasmids
pMSP3535 Nisin-inducible expression shuttle vector with pAM1 and ColE1 replicons; Ermr 3
pTCV-lacZ Shuttle vector containing promoterless lacZ; Ermr 14
pTEX5515 pMSP3535 with ebpR from bp 20 to 1561 from the ATG; this ebpR fragment contains the full ORF and the RBS of
ebpR; Ermr
This study
pTEX5586 pTCV-lacZ containing 301 bp from bp 248 upstream to bp 53 downstream of the start codon of ebpR; Ermr This study
pTEX5269 pTCV-lacZ containing 103 bp from bp 110 to 8 of the start codon of fsrB; Ermr 26
Primers
ebpR deletion Upstream fragment was amplified using GCTCTAGACAGGACCCACACTTTTCA with CGGGATCCTTTCCTCCCA
AGTCCTTT, and the downstream fragment was amplified using CGGGATCCTTGAAACCAGTGTTCCAAG with
GGAATTCTGGTCAGCAAACGATTTT
ebpR complementation The primers CCGAGCTCGGACTTGGGAGGAAACAATA and CGGGATCCAAGTCATTTCGACTTATGTCCT
were used to amplify ebpR from 20 bp upstream of the start codon to 138 bp downstream of the stop codon
ebpR promoter fusion The primers GGAATTCAAGACTACGCCGAAAACC and CGGGATCCACACGAATGATTTCTTCCA were used to
amplify from 248 bp upstream to 53 bp downstream of the start codon of ebpR.
Quantitative RT-PCR
primers
gyrB, ACCAACACCGTGCAAGCC and CAAGCCAAAACAGGTCGCC; ebpA, AAAAATGATTCGGCTCCAGAA
and TGCCAGATTCGCTCTCAAAG; srtC, ACACATGCGGTCATTTCAGG and GCGTCTTCCCATTGACTTCG
a ORF, open reading frame; RBS, ribosome binding site. ebpR ef1090. Kanr, kanamycin resistance; Fusr, fusidic acid resistance; Rif r, rifampin resistance; p-cl-Pher,
p-chloro-phenylalanine resistance; Spcr, spectinomycin resistance; Tetr, tetracycline resistance; Ermr, erythromycin resistance. Restriction enzyme recognition sites are
underlined.
FIG. 1. ebpA, srtC, and ebpR expression. (A) Real-time transcript levels of ebpA and srtC in OG1RF and TX5514 (ebpR). The numbers below
the x axis correspond to the five independent cultures used for this assay. (B) pTCV-PebpR::lacZ in OG1RF and in TX5514 streaked onto TSBG
plates containing 10 g of erythromycin/ml and 200 g of X-Gal (5-bromo-4-chloro-3-indolyl--D-galactopyranoside)/ml and incubated for 48 h
at 37°C. The negative control plasmid is pTCV-lacZ, and the positive control is pTEX5269. The -galactosidase assay results (expressed as the
optical density at 420 nm/mg of protein/ml) located under the spots correspond to a representative experiment performed with samples collected
at entry into the stationary growth phase of cultures grown in TSBG (performed in triplicate).
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munofluorescence. Binding of anti-EbpA or anti-EbpC anti-
bodies to the surface-exposed epitopes were detected using
fluorescein isothiocyanate (FITC)-labeled anti-rabbit antibod-
ies (Sigma, St. Louis, MO). First, we tested OG1RF and the
ebpA deletion mutant for the presence of pili in cells grown in
TSBG and collected in stationary phase. Using anti-EbpA,
FITC-labeled cells were detected in the OG1RF population
(Fig. 3A) but not in the ebpA mutant population. The fluores-
cence was present on the entire surface of the cells except at
the septum. Since EbpA was shown to be expressed and de-
tectable as a monomer by Western blotting in ebpB and ebpC
insertion mutants (13), these two strains were also assessed by
immunofluorescence. As shown in Fig. 3A, a fluorescent dot
(marked by an arrow and shown at a higher resolution in the
insert) was visible on a few of the ebpB insertion mutant cells,
whereas no fluorescence was detected at the surface of the
ebpC insertion mutant. In a subsequent experiment, OG1RF,
the ebpR deletion mutant, and the complemented strain were
grown under the same conditions (TSBG, stationary phase, no
nisin induction). In the OG1RF population, 15% of the cells
were labeled with FITC, whereas no fluorescence was detected
on the surface of the ebpR mutant cells (Fig. 3B). With the
complemented strain, 17% of the population was FITC labeled
(Fig. 3B, boxed numbers). We can postulate that ebpR
and/or ebpABC are influenced by and/or may influence other
FIG. 2. Western blots of OG1RF and its ebpR mutant
(TX5514). Mutanolysin surface extract preparations were probed
with anti-EbpA rabbit polyclonal immune serum. Lanes: 1, OG1RF;
2, ebpR mutant (TX5514); 3, ebpR(pMSP3535) (TX5584); 4,
ebpR(pTEX5515) (TX5582); 5, EbpA recombinant protein with a
molecular mass of 113 kDa.
FIG. 3. Immunofluorescence analysis showing surface localization of EbpA. Cells were collected at stationary growth phase from a TSBG
culture and assayed using anti-EbpA rabbit serum. The left panel is the phase-contrast image of the field visualized with the FITC filter (right
panel). (A) Parental OG1RF. TX5475 is the ebpA mutant, TX5460 is the ƒebpB mutant (ƒ, insertion mutant), and TX5448 is the ƒebpC mutant.
The area indicated with an arrow is shown in a box as an overlay between phase contrast and FITC visualization. (B) Parental OG1RF. TX5514
is the ebpR mutant; the ebpR mutant electroporated with vector only (pMSP3535) served as a control. The ebpR mutant electroporated with
pMSP3535::ebpR is the complemented strain. The boxed numbers correspond to the percentage of FITC-labeled cells from at least 250 cells
counted. Bar, 10 m.
6492 NOTES J. BACTERIOL.
regulatory pathways, since even in the presence of a functional
ebpR, the majority of the cells are not producing pili at their
surfaces. However, when cloned ebpR was transferred into the
wild type, the level of FITC-labeled cells increased to 70%
(preliminary data), whereas only 17% were labeled when the
same plasmid was introduced into the ebpR strain. These
results indicate that the level of ebpR expression affects
ebpABC expression or that the presence of the plasmid is
titrating out a negative regulator.
Strains containing mutations in the ebpABC operon were pre-
viously shown to have reduced biofilm formation (13). Since the
ebpR mutant displays greatly reduced expression of the ebpABC
operon, it was also predicted to be defective in biofilm formation.
Biofilm formation and adherence to a polystyrene surface were
assessed quantitatively as described previously (10). As shown in
Table 2, the ebpR mutant displayed a significant reduction in
biofilm formation (47% reduction, P  0.01) (Table 2). Of inter-
est, the complemented strain presented a statistically significant
increase in biofilm formation compared to OG1RF (22% more
biofilm formation, P  0.01). The biofilm defect in the ebpA and
ebpR mutants was consistent with reductions in primary adher-
ence of 43 and 64% at 30 min and 53 and 69% reduction at 2 h,
respectively (P  0.01) (Table 2).
In vivo, it has been shown that the ebpA mutant was signif-
icantly attenuated in the rat endocarditis model (13) and the
murine urinary tract infection model (17). We attempted to
quantify gene expression in vivo by using the rat endocarditis
model. Preliminary data from vegetations collected at 48 h
indicate that ebpA expression was 100 times lower in the ebpR
deletion mutant, whereas srtC expression was not appreciably
affected (preliminary results, data not shown). This experiment
demonstrates the feasibility of detecting and quantifying gene
expression in the rat endocarditis model, opening new avenues
for research directed at understanding bacterial endocarditis.
In conclusion, we identified an E. faecalis transcriptional
regulator, EbpR, which positively affects the expression of the
endocarditis-associated pilus operon, thereby influencing bio-
film formation. It will be of interest in future studies to address
the signals to which ebpR is responding and whether these
signals affect pilus production both in vitro and in vivo.
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TABLE 2. Biofilm and primary adherence assays
Strain
Median (interquartile range)
OD570 for biofilm assaya
Primary adherenceb at:
30 min 2 h
OG1RF 1.257 (1.184–1.313) 267 (238–316) 649 (614–722)
TX5475 (ebpA) 0.817 (0.766–0.882) 97 (89–123) 203 (168–229)
TX5515 (ebpR) 0.667 (0.644–0.701) 151 (114–231) 314 (230–385)
TX5584 (ebpR)/
pMSP3535
0.814 (0.750–0.891) 166 (81–202) 293 (260–429)
TX5582 (ebpR 
ebpR)
1.534 (1.487–1.674) 221 (181–290) 692 (527–750)
a The optical density at 570 nm (OD570) readings for the biofilm assays are
from three independent experiments (total of 24 wells).
b Primary adherence was assessed after incubation for 30 min and 2 h. Bacteria
in four fields from two independent plates from at least two independent exper-
iments were subjected to light microscopy and counted.
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